Neural dysfunction and metabolic imbalances in diabetic rats: Prevention by acetyl-L-carnitine

Diabetes

Volumn 43, Issue 12, 1994, Pages 1469-1477

  Ido, Yasuo ^a   McHowat, Jane ^a   Chang, Katherine C ^a   Arrigoni Martelli, Edoardo ^b   Orfalian, Zaven ^b   Kilo, Charles ^a   Corr, Peter B ^a   Williamson, Joseph R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALBUMIN; CARNITINE; DIACYLGLYCEROL; LEVACECARNINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG EFFECT; ENDONEURIUM; ENZYME ACTIVITY; MALE; NERVE CONDUCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; URINARY EXCRETION;

EID: 0028586034     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.12.1469     Document Type: Article

References (14)

1. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad J: The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 19:440-449, 1986
2. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF: Nerve glucose, fructose, sorbitol, myo and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 319:542-548,1988
3. Yue DK, Hanwell MA, Satchell PM, Turtle JR: The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes 31:789-794, 1982
4. Gillon KRW, Hawthorne JN: Sorbitol, inositol and nerve conduction in diabetes. Life Sci 32:1943-1947, 1983
5. Mayer JH, Tomlinson DR: The influence of aldose reductase inhibition and nerve wzyo-inositol on axonal transport and nerve conduction velocity in rats with experimental diabetes (Abstract). J Physiol 340:25P, 1983
6. Greene DA, Lattimer S, Ulbrecht J, Carroll P: Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8:290-299, 1985
7. Sima AAF, Bril V, Nathaniel V, McEvren TAJ, Brown MD, Lattimer SA, Greene DA: Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 319:548-555, 1988
8. Sima AAF, Prashar A, Zhang W-X, Chakrabarti S, Greene DA: Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic bio-breeding rat. J Clin Invest 85:1410-1420, 1990
9. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton KG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
10. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR: Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 38:1258-1270, 1989
11. Winegrad AI: Does a common mechanism induce the diverse complications of diabetes? Diabetes 36:396-406, 1987
12. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA: Complications: neuropathy, pathogenetic considerations. Diabetes Care 15:1902-1925, 1992
13. +-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition. Diabetes 37:558-562, 1988
14. +-ATPase activity are altered in nerve and retina from the Zucker diabetic fatty rat (ZDF/Gmi-fα) (Abstract). Diabetes 42 (Suppl. 1):101A, 1993